LBI-HTA - Publications - Search - Year: 2001
Number of items: 45.

Wild, C. (2001): [HTA link list]. HTA-Newsletter 03: 4.

Wild, C. (2001): [Botulinim toxin and other spasmolytics for treatment of spasticity]. HTA-Newsletter 03: 3.

Wild, C. (2001): [Drug treatments for Alzheimer's disease]. HTA-Newsletter 03: 3-4.

Wild, C. (2001): [Hyperbaric oxygen]. HTA-Newsletter 03: 2.

Wild, C. (2001): [Sacral neuromodulation in the treatment of urinary incontinence]. HTA-Newsletter 03: 2-3.

Wild, C. (2001): [HTA newsletter]. ITA-Newsletter December 2001: 11.

Wild, C. (2001): [Project on generics: Saving 5 million schilling]. ITA-Newsletter December 2001: 10.

Wild, C. (2001): [Stem cell research, quo vadis? Editorial]. HTA-Newsletter 03: 1-2.

Wild, C. (2001): [Innovations and (expensive) followers]. ITA-Newsletter December 2001: 9.

Wild, C. (2001): [Limits of the evidence-based medicine: Conflicts of interests]. ITA-Newsletter December 2001: 10.

Wild, C. (2001): [Brachytherapy for prostate cancer]. HTA-Newsletter 02: 3.

Wild, C. (2001): [Tension free vaginal tape (TVT) for urinary incontinence of women]. HTA-Newsletter 02: 2-3.

Wild, C. (2001): [Autologous chondrocyte transplantation (ACI) in treating cartilage damage]. HTA-Newsletter 02: 2.

Wild, C. (2001): [Cytomegalovirus prophylaxis and therapy]. HTA-Newsletter 02: 3-4.

Wild, C. (2001): [Generics and cost reduction: A project in Austria]. HTA-Newsletter 02: 4.

Wild, C. (2001): [Innovations and (expensive) followers. Editorial]. HTA-Newsletter 02: 1-2.

Wild, C. (2001): [Immunoglobulins: Effectiveness and costs]. ORF ON Science.

Wild, C. (2001): [Stem cell research, quo vadis?]. ORF ON Science.

Wild, C. (2001): [Chronic fatigue syndrome]. HTA-Newsletter 01: 2.

Wild, C. (2001): [Limitations of evidence based medicine. Editorial]. HTA-Newsletter 01: 1.

Wild, C. (2001): [Extracorporeal shock wave therapy in orthopedics]. HTA-Newsletter 01: 4.

Wild, C. (2001): [Treatment of autism]. HTA-Newsletter 01: 3-4.

Wild, C. (2001): [European Collaboration in HTA]. HTA-Newsletter 01: 4.

Wild, C. (2001): [Age related macular degeneration. Photodynamic therapy]. HTA-Newsletter 01: 3.

Wild, C. (2001): [Erythropoietin for anaemic tumour patients]. HTA-Newsletter 01: 2.

Wild, C. (2001): [Stem cells: Quo vadis?]. ITA-Newsletter September 2001: 8-9.

Wild, C. (2001): [Health Technology Assessment and decision making. Editorial]. HTA-Newsletter 00: 1-2.

Wild, C. and Jonas, S. (2001): [Immunoglobulins in transplant medicine: Prevention and therapy of cytomegalovirus infections]. ITA-Newsletter September 2001: 9-10.

Wild, C. (2001): [European HTA project comes to an end in September]. ITA-Newsletter September 2001: 10-11.

Wild, C. (2001): Screening in Austria - the cases of mammography, PSA-testing and routine use of ultrasonography in pregnancy. International Journal of Technology Assessment in Health Care 17 (03): 305-315.

Jonas, S. and Wild, C. and Schmetterer, L. and Sycha, T. and Frank, W. (2001): [Immunoglobulins in transplant medicine: Prevention and therapy of cytomegalovirus infections. Systematic review and meta-analysis]. ITA-Projektbericht 19.

Busse, R. and Orvain, J. and Drummond, M. and Wild, C. (2001): Best practice in undertaking and reporting HTA. Working Group 4 Final Report. Projektbericht.

Wild, C. and Jonas, S. and Frank, W. and Traunmüller, F. (2001): [Invasive aspergillosis: State of the art in diagnosis, treatment and conditions. An assessment]. ITA-Projektbericht 18.

Wild, C. (2001): [Approval of innovative drugs]. ORF ON Science.

Wild, C. (2001): [Evidence-based medicine: Continuing education for diabetologists].

Wild, C. and Perleth, M. (2001): Possibilities for partial integration of Health Technology Assessment (HTA) and Technology Assessment (TA). TA-Datenbank-Nachrichten 10 (01): 55-58.

Wild, C. (2001): [Assessing medical interventions: Erythropoietin in tumour anaemia]. TA-Datenbank-Nachrichten (01, Sonderheft): 51-55.

Wild, C. (2001): [IOM report "To Err is Human"]. ITA-Newsletter March 2001: 8-9.

Wild, C. (2001): [International symposium on health technology assessment]. ITA-Newsletter March 2001: 9.

Wild, C. (2001): [Building a safer health system]. ORF ON Science.

Wild, C. (2001): [Swedish EU presidency puts emphasis on health policy]. ORF ON Science.

Wild, C. and Perleth, M. (2001): [Health technology assessment: An introduction]. TA-Datenbank-Nachrichten 10 (01): 6-12.

Wild, C. (2001): [Assessing medical interventions]. ManagMed (3).

Wild, C. and Jonas, S. (2001): [Health policy decisions between rationing and rationalisation as demonstrated by the example of erythropoietin in tumour anaemia]. Das Gesundheitswesen 63 (2): 221-225.

Wild, C. and Jonas, S. and Frank, W. and Schmetterer, L. and Sycha, T. (2001): [Immunoglobulins in transplant medicine. Prevention and therapy of cytomegalovirus infections: An Assessment]. European Surgery: Acta Chirurgica Austriaca 33 (Supplement 178).

This list was generated on Mon Mar 27 00:00:13 2017 CEST.